Title: EVIDENCE FOR CYCLIC GUANOSINE MONOPHOSPHATE IMPAIRMENT IN ACUTE DECOMPENSATED HEART FAILURE PATIENTS
Abstract: Cyclic guanosine monophosphate (cGMP) plays a key role in cardiorenal protection. After activation of guanylyl cyclase receptor A (GC-A) by atrial natriuretic peptide (ANP) and b-type natriuretic peptide (BNP), plasma and urinary cGMP increases. To date, plasma and urinary cGMP in human heart
Publication Year: 2019
Publication Date: 2019-03-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot